Back to results
US 2024/0390432 A1Published application
Engineered vectors and organisms containing the same for isoflavone conversion in the gut
AssigneeBoard of Regents, The University of Texas System
InventorJustyn JAWORSKI
Life of this patent
Estimating the term…
Abstract
Generally, the present disclosure contemplates engineered vectors, organisms (e.g., bacteria or bacteriophage) containing the same, and methods for treating the gut of mammalian species by providing the organism containing the engineered vector to the gut of a mammal. Example engineered organisms can include one or more genes isolated from microbial populations for promoting isoflavone metabolism.
Claims20
1-24. (canceled)
A method for modifying the phenotype of a mammalian gut comprising:
- introducing to the mammalian gut a probiotic for the treatment of cardiovascular disease (CVD) comprising:
- a bacterium from the genus Escherichia containing therein at least two stable plasmids for isoflavone metabolism, said plasmids providing one or more components of isoflavone metabolism for converting Daidzein to Equol, Genistein to 5-Hydroxy-Equol, or both.
35-37. (canceled)
Dependencies are inferred from the claim text.